WO2004085683A3 - Verfahren zur frühdiagnose von carcinomen und testkit zu dessen durchführung - Google Patents

Verfahren zur frühdiagnose von carcinomen und testkit zu dessen durchführung Download PDF

Info

Publication number
WO2004085683A3
WO2004085683A3 PCT/EP2004/003044 EP2004003044W WO2004085683A3 WO 2004085683 A3 WO2004085683 A3 WO 2004085683A3 EP 2004003044 W EP2004003044 W EP 2004003044W WO 2004085683 A3 WO2004085683 A3 WO 2004085683A3
Authority
WO
WIPO (PCT)
Prior art keywords
carrying
test kit
early carcinoma
carcinoma detection
papilloma virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/003044
Other languages
English (en)
French (fr)
Other versions
WO2004085683A2 (de
Inventor
Ralf Hilfrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BUCHNER ERWIN
Original Assignee
BUCHNER ERWIN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BUCHNER ERWIN filed Critical BUCHNER ERWIN
Priority to EP04722574A priority Critical patent/EP1656561A2/de
Priority to JP2006504811A priority patent/JP2006521104A/ja
Publication of WO2004085683A2 publication Critical patent/WO2004085683A2/de
Publication of WO2004085683A3 publication Critical patent/WO2004085683A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur frühen Diagnose von Carcinomen und ihren Vorstufen, die durch humane Papillomviren hervorgerufen werden oder eine Assoziation zu humanen Papillomviren aufweisen, anhand von Körperproben. In dem Verfahren wird bestimmt, ob ein virales Proteins der humanen Papillomviren exprimiert wird. Das virale Protein ist ein Capsidprotein, insbesondere das majore Capsidprotein Ll. Ausserdem betrifft die Erfindung ein Testkit zur Durchführung des Verfahrens.
PCT/EP2004/003044 2003-03-25 2004-03-23 Verfahren zur frühdiagnose von carcinomen und testkit zu dessen durchführung Ceased WO2004085683A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP04722574A EP1656561A2 (de) 2003-03-25 2004-03-23 Verfahren zur frühdiagnose von carcinomen und testkit zu dessen durchführung
JP2006504811A JP2006521104A (ja) 2003-03-25 2004-03-23 癌腫の早期診断法及びこれを行うための検査キット

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10313388.7 2003-03-25
DE10313388 2003-03-25

Publications (2)

Publication Number Publication Date
WO2004085683A2 WO2004085683A2 (de) 2004-10-07
WO2004085683A3 true WO2004085683A3 (de) 2005-01-06

Family

ID=33038757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/003044 Ceased WO2004085683A2 (de) 2003-03-25 2004-03-23 Verfahren zur frühdiagnose von carcinomen und testkit zu dessen durchführung

Country Status (3)

Country Link
EP (1) EP1656561A2 (de)
JP (1) JP2006521104A (de)
WO (1) WO2004085683A2 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8916342B2 (en) 2006-11-13 2014-12-23 Oncohealth Corp. Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1936379A1 (de) * 2006-12-21 2008-06-25 BUCHNER, Erwin Verfahren zum Nachweis einer aktiven HPV-Infektion in biologischen Proben durch einen Sandwich-ELISA sowie Testkit zur Durchführung des Verfahrens
EA019836B1 (ru) * 2007-11-02 2014-06-30 Те Джонс Хопкинс Юниверсити Композиции многотипных пептидов hpv и способы лечения или предотвращения папилломавирусной инфекции у человека

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332596A1 (de) * 1993-09-24 1995-03-30 Martin Josef Dr Sapp Monoklonale Antikörper
US5985610A (en) * 1992-09-03 1999-11-16 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
US6165471A (en) * 1997-07-03 2000-12-26 University Of Colorado, University Technology Corporation Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
WO2003020975A2 (en) * 2001-08-31 2003-03-13 Norchip A/S OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985610A (en) * 1992-09-03 1999-11-16 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE4332596A1 (de) * 1993-09-24 1995-03-30 Martin Josef Dr Sapp Monoklonale Antikörper
US6165471A (en) * 1997-07-03 2000-12-26 University Of Colorado, University Technology Corporation Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
WO2003020975A2 (en) * 2001-08-31 2003-03-13 Norchip A/S OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MCMURRAY H R ET AL: "Biology of human papillomaviruses", INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, vol. 82, no. 1, February 2001 (2001-02-01), pages 15 - 33, XP002301425, ISSN: 0959-9673 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916342B2 (en) 2006-11-13 2014-12-23 Oncohealth Corp. Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8865162B2 (en) 2008-06-13 2014-10-21 Oncohealth Corp. Monoclonal antibodies against HPV proteins
US9568474B2 (en) 2008-06-13 2017-02-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers

Also Published As

Publication number Publication date
EP1656561A2 (de) 2006-05-17
JP2006521104A (ja) 2006-09-21
WO2004085683A2 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
AU2001278452A1 (en) Method for the detection of influenza a/b viruses
DE60228557D1 (de) Candida-nachweis
ATE540319T1 (de) Verfahren für die bestimmung von fk506
JP2004503248A5 (de)
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
WO2006033662A3 (en) Methods and kits for detection of multiple pathogens
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
DE60013287D1 (de) Früherkennung der flaviviren unter verwendung des ns1-glycoproteins
WO2005016132A3 (en) Diagnostics for sars virus
WO2004022006A3 (en) Methods of diagnosing cervical cancer
DE60333120D1 (de) Verfahren zur bestimmung derendothel-abhängigen vasoaktivität
WO2007006031A3 (en) Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them
WO2002021133A3 (en) Methods of detecting cancer based on prostasin
WO2003089934A3 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/lap-1
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
WO2002075308A3 (en) A kit and method for detecting food allergies
WO2002090989A3 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2003020204A3 (en) Detection of bovine viral diarrhea virus in tissue samples
EP0836652A4 (de) Methoden, probensätze und zusammensetzungen für den nachweis von papillomavirus
DE50107569D1 (de) Nachweis von humanen papillomviren
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
WO2005029089A3 (en) Method of diagnosing ovarian endometriosis using tfpi-2 protein
WO2005040754A3 (en) METHOD AND KIT FOR DETECTING LISTERIA spp.
WO2004002294B1 (en) Plasma or serum marker and process for detection of cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006504811

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004722574

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004722574

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004722574

Country of ref document: EP